A recent study has shown that anti-PD-L1 antibody treatment in combination with IL-15 reduces PD-1 expression on CD8+ T cells in murine metastatic colon cancer resulting in enhanced IFN-γ secretion and prolonged survival of tumor bearing animals [27]. This evidence concerns the gene CD8A and neoplasm.